Viewing Study NCT05350969


Ignite Creation Date: 2025-12-24 @ 10:56 PM
Ignite Modification Date: 2025-12-25 @ 8:24 PM
Study NCT ID: NCT05350969
Status: COMPLETED
Last Update Posted: 2025-07-03
First Post: 2022-04-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction
Sponsor: Cardior Pharmaceuticals GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module